Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.21.2
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2021
Stock-Based Compensation [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following table provides the assumptions used to determine the grant date fair value of the market condition-dependent / TSR goal-based portion of the Company’s performance stock units granted during the nine months ended September 30, 2021 using a Monte Carlo simulation:
Expected dividend yield —  %
Risk-free interest rate 0.20  %
Expected volatility 41.70  %
Expected term (in years) 2.95
Grant date fair value $ 13.21 
Schedule of Nonvested Restricted Stock and Performance Stock Unit Activity
The following table summarizes the activity for the Company’s restricted stock units and performance stock units for the nine months ended September 30, 2021:
Restricted Stock Units Performance Stock Units
Number of
Units		 Weighted Average Grant Date Fair Value (per share) Number of
Units		 Weighted Average Grant Date Fair Value (per share)
Nonvested as of December 31, 2020 1,841,139  $ 16.14  965,736  $ 17.69 
Granted 1,697,623  $ 15.39  211,985  $ 13.21 
Vested (773,619) $ 16.00  —  $ — 
Forfeited (69,877) $ 15.83  (15,211) $ 16.75 
Nonvested as of September 30, 2021 2,695,266  $ 15.71  1,162,510  $ 16.92 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based compensation expense for the Company is as follows:
Three months ended
September 30,		 Nine months ended
September 30,
2021 2020 2021 2020
Continuing operations 10,193  4,355  $ 22,837  $ 13,324 
Discontinued operations 4,375  1,782  8,066  5,099 
Stock-based compensation expense 14,568  6,137  30,903  18,423 
Continuing operations (2,494) (1,079) (5,589) (3,301)
Discontinued operations (1,071) (442) (1,974) (1,264)
Income tax benefit (3,565) (1,521) (7,563) (4,565)
Continuing operations 7,699  3,276  17,248  10,023 
Discontinued operations 3,304  1,340  6,092  3,835 
Stock-based compensation expense, net of income tax benefit $ 11,003  $ 4,616  $ 23,340  $ 13,858